U.S. markets closed

Encompass Health Corporation (EHC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
67.39-0.13 (-0.19%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/24/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
6.70B6.16B6.36B6.83B6.24B
Enterprise Value 3
10.14B9.69B9.62B10.12B9.07B
Trailing P/E
23.4017.9517.6921.5820.35
Forward P/E 1
16.8618.2817.7318.2516.89
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
1.461.321.381.531.43
Price/Book (mrq)
4.584.264.715.124.89
Enterprise Value/Revenue 3
2.209.028.148.557.81
Enterprise Value/EBITDA 6
11.6158.1940.4245.9436.38

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 3-0.15%
S&P500 52-Week Change 314.01%
52 Week High 383.30
52 Week Low 348.01
50-Day Moving Average 365.18
200-Day Moving Average 366.35

Share Statistics

Avg Vol (3 month) 3538.17k
Avg Vol (10 day) 3358.86k
Shares Outstanding 599.45M
Float 97.69M
% Held by Insiders 11.53%
% Held by Institutions 193.77%
Shares Short (Sep 29, 2020) 42.27M
Short Ratio (Sep 29, 2020) 43.78
Short % of Float (Sep 29, 2020) 42.92%
Short % of Shares Outstanding (Sep 29, 2020) 42.29%
Shares Short (prior month Aug 30, 2020) 41.77M

Dividends & Splits

Forward Annual Dividend Rate 41.12
Forward Annual Dividend Yield 41.66%
Trailing Annual Dividend Rate 31.12
Trailing Annual Dividend Yield 31.66%
5 Year Average Dividend Yield 41.90
Payout Ratio 438.89%
Dividend Date 3Oct 14, 2020
Ex-Dividend Date 4Dec 30, 2020
Last Split Factor 21:5
Last Split Date 3Oct 25, 2006

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 6.21%
Operating Margin (ttm)13.40%

Management Effectiveness

Return on Assets (ttm)6.26%
Return on Equity (ttm)19.29%

Income Statement

Revenue (ttm)4.6B
Revenue Per Share (ttm)46.89
Quarterly Revenue Growth (yoy)-5.40%
Gross Profit (ttm)1.86B
EBITDA 849.8M
Net Income Avi to Common (ttm)284.7M
Diluted EPS (ttm)2.87
Quarterly Earnings Growth (yoy)-63.30%

Balance Sheet

Total Cash (mrq)419M
Total Cash Per Share (mrq)4.21
Total Debt (mrq)3.86B
Total Debt/Equity (mrq)207.03
Current Ratio (mrq)1.66
Book Value Per Share (mrq)14.72

Cash Flow Statement

Operating Cash Flow (ttm)581.6M
Levered Free Cash Flow (ttm)23.98M